Ceribell (CBLL) Cash & Equivalents (2023 - 2026)

Ceribell (CBLL) has 4 years of Cash & Equivalents data on file, last reported at $45.3 million in Q1 2026.

• Quarterly Cash & Equivalents fell 70.49% year-over-year to $45.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.3 million (down 70.49% YoY) and the FY2025 annual result came in at $40.5 million, down 79.18% from the prior year.
• Cash & Equivalents rose to $45.3 million in Q1 2026, from $40.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $194.4 million in Q4 2024 to a low of $14.1 million in Q3 2024.
• A 4-year average of $68.2 million and a median of $40.3 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 463.47% — and 2025, when it plunged 79.18%.
• Tracing CBLL's Cash & Equivalents over 4 years: stood at $34.5 million in 2023, then soared by 463.47% to $194.4 million in 2024, then sank by 79.18% to $40.5 million in 2025, then climbed by 11.8% to $45.3 million in 2026.
• The last three Cash & Equivalents figures came in at $45.3 million (Q1 2026), $40.5 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.